• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dissolving intravenous cyclosporin A in a fat emulsion carrier prevents acute renal side effects in the rat.

作者信息

Tibell A, Larsson M, Alvestrand A

机构信息

Department of Transplantation Surgery, Huddinge Hospital, Sweden.

出版信息

Transpl Int. 1993 Mar;6(2):69-72. doi: 10.1007/BF00336647.

DOI:10.1007/BF00336647
PMID:8447927
Abstract

Cyclosporin A (CyA)-induced nephrotoxicity is still a serious clinical problem. The nephrotoxicity seems to be more pronounced when CyA (solubilized in water with Cremophore EL, as in Sandimmun) is given intravenously than when it is given orally. Using soybean oil in which CyA was dissolved, we prepared an intravenous fat emulsion without an artificial detergent, such as Cremophore EL. The renal effects of our new formula were compared with those of Sandimmun and Cremophore EL in a rat model. CyA in the fat emulsion did not significantly affect the glomerular filtration rate (GFR). Both Sandimmun and Cremophore EL significantly reduced the GFR. These results suggest that a change in the vehicle may obviate the acute nephrotoxic side effects caused by intravenous administration of CyA solubilized by Cremophore EL.

摘要

相似文献

1
Dissolving intravenous cyclosporin A in a fat emulsion carrier prevents acute renal side effects in the rat.
Transpl Int. 1993 Mar;6(2):69-72. doi: 10.1007/BF00336647.
2
Cyclosporin A in fat emulsion carriers: studies on the immunosuppressive potential, using the heterotopic heart transplant model in rats.脂肪乳剂载体中的环孢素A:利用大鼠异位心脏移植模型对其免疫抑制潜力的研究
Transpl Int. 1994;7(6):438-41. doi: 10.1007/BF00346039.
3
Cyclosporin A in fat emulsion carriers: experimental studies on pharmacokinetics and tissue distribution.脂肪乳剂载体中的环孢素A:药代动力学和组织分布的实验研究
Pharmacol Toxicol. 1995 Feb;76(2):115-21. doi: 10.1111/j.1600-0773.1995.tb00115.x.
4
Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.抑制中性内肽酶可增强心房利钠肽对急性环孢素诱导的肾毒性的作用。
Nephron. 2000 Nov;86(3):298-305. doi: 10.1159/000045785.
5
Effects of a selective adenosine A1 receptor antagonist on the development of cyclosporin nephrotoxicity.一种选择性腺苷A1受体拮抗剂对环孢素肾毒性发展的影响。
Br J Pharmacol. 1996 Mar;117(5):879-84. doi: 10.1111/j.1476-5381.1996.tb15275.x.
6
Cyclosporin reduces renal blood flow through vasoconstriction of arcuate arteries in the hydronephrotic rat model.在肾积水大鼠模型中,环孢素通过弓状动脉血管收缩减少肾血流量。
Klin Wochenschr. 1990 Feb 1;68(3):166-74. doi: 10.1007/BF01649080.
7
Cyclosporine A in fat emulsion carrier: immunosuppressive effect in vitro.以脂肪乳剂为载体的环孢素A:体外免疫抑制作用
Scand J Immunol. 1992 Feb;35(2):231-6. doi: 10.1111/j.1365-3083.1992.tb02855.x.
8
Use of the isolated perfused kidney model to assess the acute pharmacologic effects of cyclosporine and its vehicle, cremophor EL.
Transplantation. 1987 Aug;44(2):195-201. doi: 10.1097/00007890-198708000-00005.
9
Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.285例糖尿病患者接受环孢素A治疗8至13年后的肾功能正常情况。
Diabetes Metab Res Rev. 2002 Nov-Dec;18(6):464-72. doi: 10.1002/dmrr.325.
10
Thromboxane receptor blockade improves cyclosporine nephrotoxicity in rats.血栓素受体阻断可改善大鼠的环孢素肾毒性。
Prostaglandins. 1990 Feb;39(2):135-46. doi: 10.1016/0090-6980(90)90070-c.

引用本文的文献

1
Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapy.转化研究中的纳米乳剂——靶向癌症治疗的机遇与挑战
AAPS PharmSciTech. 2014 Jun;15(3):694-708. doi: 10.1208/s12249-014-0088-9. Epub 2014 Feb 8.
2
Injectable lipid emulsions-advancements, opportunities and challenges.可注射脂肪乳剂——进展、机遇与挑战。
AAPS PharmSciTech. 2010 Dec;11(4):1526-40. doi: 10.1208/s12249-010-9526-5. Epub 2010 Oct 26.